1. Office intrauterine morcellation for retained products of conception.
- Author
-
Damiani, Gianluca Raffaello, Di Gennaro, Daniele, Vimercati, Antonella, Cicinelli, Ettore, Perrone, Anna Myriam, De Iaco, Pierandrea, Malvasi, Antonio, Gaetani, Maria, Cascardi, Eliano, Cazzato, Gerardo, Dellino, Miriam, Pellegrino, Antonio, and Vitagliano, Amerigo
- Subjects
- *
TISSUE adhesions , *ACADEMIC medical centers , *PLACENTA diseases , *MISCARRIAGE , *LAPAROSCOPIC surgery , *UTERINE diseases , *ABORTION , *PREGNANCY complications , *DESCRIPTIVE statistics , *LABOR complications (Obstetrics) , *HYSTEROSCOPY , *CESAREAN section , *DELIVERY (Obstetrics) , *LONGITUDINAL method , *WOMEN'S health - Abstract
Proposing hysteroscopic morcellation (HM) as a surgical-therapeutic approach in the treatment of retained products of conception (RPOC) to prevent intrauterine adhesions (IUAs). Prospective analysis. A teaching and university hospital. Women with RPOC. Office -HM with 'Truclear 5 C'. Twenty-two consecutive patients presenting with trophoblastic residue retention after miscarriage and interruption of pregnancy or placenta remnants after cesarean section or delivery were enrolled. These women underwent office-HM with 'Truclear 5 C'. Primary outcomes were median time and rate of hospitalization. The quality of the specimen was also analyzed. A hysteroscopic second look for IUAs was performed. Mean procedure time was six minutes (SD ± 5). Tissue samples had a mean collection size 2.5 cm3+0.9. 38% of the samples had spotting or abnormal vaginal discharge. Dilatation of the cervical canal was not performed in any case. Second-look hysteroscopy did not show any de novo IUAs in any of the enrolled patients. In the hysteroscopic treatment of RPOC, HM is a valid choice in an office setting without the use of cervical dilatation. Removal of RPOC was uneventful in all cases, simple and carried out faster without any adverse outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF